Medical Writing and Publication Support
Clear, accurate and compliant scientific documentation for every stage of clinical development, registration and publication, prepared by medical writers who master both the science and the expectations of each audience.
The quality of your documentation shapes how regulators, ethics committees, investigators and the scientific community perceive your product. A well-constructed protocol progresses through approval efficiently, a rigorous clinical study report anticipates the reviewer’s questions, and a compelling manuscript gives your results the visibility they deserve.
Our medical writers bring backgrounds in medicine, pharmacy and the life sciences, and collaborate daily with our clinical operations, biostatistics, pharmacovigilance and regulatory teams. They understand the studies behind every document and the expectations of every reader.
Each document undergoes scientific review and comprehensive quality control against its source data before delivery, so you receive a document ready for approval rather than a draft requiring revision.

Documentation across the full product lifecycle
From the first protocol to the final publication, our medical writers prepare the documents on which regulators, ethics committees, investigators and the scientific community depend.
Clinical trial protocols and amendments
Comprehensive protocols following ICH M11 and SPIRIT, and well-justified amendments when a study must evolve.
Informed consent documents
Participant information and consent forms in Arabic and English, written in clear and respectful language.
Investigator’s brochures
Initial brochures and annual updates consolidating the clinical and non-clinical evidence on the investigational product.
Clinical study reports
Full and abbreviated clinical study reports in line with ICH E3, including synopses and appendices.
CTD clinical summaries and overviews
Module 2.5 clinical overviews and Module 2.7 clinical summaries for registration dossiers.
Clinical evaluation reports
Clinical evaluation reports for medical devices, founded on a systematic appraisal of the clinical evidence.
Safety narratives
Precise, well-structured narratives for serious adverse events and other events of special interest.
Periodic safety reports
Development safety update reports (DSURs) and periodic benefit-risk evaluation reports (PBRERs), prepared jointly with our pharmacovigilance team.
Risk management plans
Risk management plans and their updates, characterising the safety profile and the measures to minimise risk.
Responses to regulatory questions
Well-reasoned, fully referenced responses to enquiries from the Egyptian Drug Authority and other regulators.
A rigorous path from brief to final document
- 01
Brief and planning
The purpose, audience, governing guideline, timeline and review cycles are agreed for each document at the outset.
- 02
Source evaluation
Our writers examine the protocol, data, statistical outputs and literature, and resolve open questions before drafting begins.
- 03
Drafting
The first draft follows the applicable guideline and your template, built around key messages agreed with you in advance.
- 04
Expert review
Our medical, statistical and regulatory specialists review the draft for scientific accuracy and soundness of interpretation.
- 05
Quality control
Every figure, table and reference is verified against its source, and the document is checked for consistency and style.
- 06
Finalisation
Reviewer comments are consolidated and resolved with you, and a final, version-controlled document is delivered.
Bringing your findings to the scientific community
Robust research merits a wide and informed readership. We support the publication of your results and their clear communication to healthcare professionals and patients.
- 01
Journal manuscripts
Original research articles following CONSORT, STROBE and ICMJE recommendations, from first draft through to acceptance.
- 02
Journal selection and submission
Guidance on target journals, preparation of the submission package and considered responses to peer reviewers.
- 03
Abstracts, posters and presentations
Congress abstracts, scientific posters and presentations for national and international meetings.
- 04
Systematic and literature reviews
Structured appraisals of the published evidence to inform study design, regulatory submissions and publications.
- 05
Plain-language summaries
Summaries of study results for participants and the public, in Arabic and English.
- 06
Medical education materials
Scientifically accurate materials for healthcare professionals, reviewed for balance and compliance.
Aligned with the guidelines that govern each document
- 01
ICH E3, M11 and M4
Structure and content of clinical study reports, clinical protocols and the Common Technical Document.
- 02
ICH E2F and E2C (R2)
Development safety update reports and periodic benefit-risk evaluation reports.
- 03
CONSORT, STROBE and ICMJE
Reporting standards for trials and observational studies, and recommendations for journal publication.
- 04
Good Publication Practice
Ethical and transparent publication of company-sponsored research.
More from our clinical research team
Clinical Studies Management
Our flagship full-service offering, from feasibility to the final clinical study report.
Protocol Development
Protocols, consent forms and essential study documents designed for approval and flawless execution.
Site Selection and Management
Rigorously selected investigators and sites, supported from feasibility to close-out.
Clinical Monitoring
Risk-based monitoring to local and global multinational standards.
Data Management and Biostatistics
Validated data on Insight EDC and statistical analysis that withstands scrutiny.
